Technology & Software Global On demand · 24-48h

Global AI Ultrasound Solution Market Strategic Research Report

Global AI Ultrasound Solution Market Strategic Research Repo…
$3,500 USD
Market Research Reports
Strategic Research Report
Global AI Ultrasound Solution Market
$2.3B2025
20.6%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Platform, Software, Hardware

By Application: Hospital, Clinic, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Butterfly Network, GE HealthCare, Philips, Siemens Healthineers, Canon Medical, Samsung Medison, Clarius, Exo, UltraSight, DiA Imaging, Us2.ai, Ultromics, See-Mode Technologies, Deepwise, INFERVISION TECHNOLOGY, Lianying Intelligent Medical Technology (United Imaging), SmartAlpha, Demetics Medical Technology

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 138 pages
Market size 2025
$2.3B
Billion USD
Forecast CAGR
20.6%
2025-2032
Forecast 2032
$8.5B
Projected
区域
5
Asia Pacific · Latin America · MEA · Europe · North America

概述

Scope of the Report

The global AI Ultrasound Solution market size is predicted to grow from US$ 2,299 million in 2025 to US$ 8,507 million in 2032; it is expected to grow at a CAGR of 20.6% from 2026 to 2032.

AI Ultrasound Solutions refer to ultrasound imaging systems enhanced by artificial intelligence algorithms that assist clinicians in image acquisition, interpretation, quantification, and clinical decision-making. These solutions typically combine ultrasound hardware (handheld, portable, or cart-based systems) with AI software capable of real-time scan guidance, automated anatomy recognition, measurement, and disease detection. By reducing operator dependency and standardizing image quality, AI ultrasound addresses long-standing limitations of conventional ultrasound, such as variability in skill levels and workflow inefficiencies. Commercially, AI ultrasound is positioned across point-of-care ultrasound (POCUS), emergency medicine, critical care, obstetrics, cardiology, and general imaging. Depending on regulatory clearance, products may function as clinical decision support tools or as regulated Software as a Medical Device (SaMD), with increasing emphasis on explainability, real-time feedback, and seamless integration into clinical workflows.

From a multi-angle classification perspective, the market can be parameterized by device form factor (handheld, cart-based, wearable), clinical application (POCUS, ICU, obstetrics, cardiology, lung and abdominal imaging), AI functional depth (scan guidance, automated measurements, disease classification, workflow automation), deployment model (on-device edge AI, hybrid edge–cloud, cloud-based SaaS), and commercialization status (research/training use, clinical decision support, fully regulated diagnostic systems). These dimensions reflect real-world purchasing behavior, as customers balance portability, performance, regulatory compliance, and IT constraints when selecting AI-enabled ultrasound solutions.

The value chain begins upstream with ultrasound transducer and system manufacturers, semiconductor and computing component suppliers, and data annotation partners. Midstream players include AI algorithm developers, software platform providers, and cloud infrastructure vendors. Downstream customers consist mainly of hospitals, emergency departments, outpatient clinics, and primary care providers, with growing adoption in remote and resource-limited settings. System integrators and distributors often play a role in deployment, training, and maintenance, particularly for enterprise and multi-site installations.

Cost structures are dominated by R&D, algorithm training, clinical validation, and regulatory compliance, representing high fixed costs, while variable costs include cloud computing, software updates, and customer support. Gross margins are generally favorable for software-heavy offerings, though device-integrated solutions may show lower margins due to hardware costs. Transactions typically involve pilot evaluations, followed by subscription-based or per-device licensing models, sometimes bundled with hardware sales. Market trends point toward rapid growth in handheld and POCUS applications, deeper AI automation at the edge, broader regulatory approvals, and expanding use in primary care and global health scenarios.

This report presents a comprehensive overview of the global AI Ultrasound Solution market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Platform
  • Software
  • Hardware

Segment by AI Functional Depth

  • Anatomical Guidance & Probe Positioning
  • Pattern Recognition Systems
  • Quantitative Scoring Systems
  • Others

Segment by Deployment & Architecture Model

  • On-premise
  • Private Cloud (Hospital-owned Cloud)
  • Public Cloud / SaaS
  • Others

Segment by Application

  • Hospital
  • Clinic
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global AI Ultrasound Solution market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospital, Clinic, Other evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global AI Ultrasound Solution Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 20.6%
Regional growth momentum
Market share by segment
Key metrics
Base value
$2.3B
2025
Forecast
$8.5B
2032
CAGR
20.6%
2025–2032
区域
5
global
Key companies
Butterfly NetworkGE HealthCarePhilipsSiemens HealthineersCanon MedicalSamsung MedisonClariusExo
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
PlatformSoftwareHardware
By Application
HospitalClinicOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Platform
  • 3.1.3 Software
  • 3.1.4 Hardware
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospital
  • 4.1.3 Clinic
  • 4.1.4 Other
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Butterfly Network
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 GE HealthCare
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Philips
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Siemens Healthineers
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Canon Medical
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Samsung Medison
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Clarius
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Exo
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 UltraSight
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 DiA Imaging
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Us2.ai
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Ultromics
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 See-Mode Technologies
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Deepwise
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 INFERVISION TECHNOLOGY
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Lianying Intelligent Medical Technology (United Imaging)
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 SmartAlpha
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Demetics Medical Technology
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global AI Ultrasound Solution market?
The global AI Ultrasound Solution market is estimated at US$ 2.3 billion in 2025 (base year) and is projected to reach US$ 8.51 billion by 2032.
What is the forecast CAGR for the AI Ultrasound Solution market?
The market is expected to grow at a CAGR of 20.6% from 2026 to 2032, expanding from US$ 2.3 billion in 2025 to US$ 8.51 billion in 2032, roughly 3.7 times its base-year value.
What is AI Ultrasound Solution?
AI Ultrasound Solutions refer to ultrasound imaging systems enhanced by artificial intelligence algorithms that assist clinicians in image acquisition, interpretation, quantification, and clinical decision-making. These solutions typically combine ultrasound hardware (handheld, portable, or cart-based systems) with AI software capable of real-time scan guidance, automated anatomy recognition, measurement, and disease detection.
What are the main segments of the AI Ultrasound Solution market by type?
By type, the market is segmented into Platform, Software and Hardware.
Which applications drive demand in the AI Ultrasound Solution market?
Key applications covered include Hospital, Clinic and Other.
Who are the key players in the AI Ultrasound Solution market?
Key players profiled include Butterfly Network, GE HealthCare, Philips, Siemens Healthineers, Canon Medical, Samsung Medison, Clarius and Exo, among 18 companies covered in total.
Which regions and countries are covered for AI Ultrasound Solution?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What challenges does the AI Ultrasound Solution market face?
These dimensions reflect real-world purchasing behavior, as customers balance portability, performance, regulatory compliance, and IT constraints when selecting AI-enabled ultrasound solutions.
Who should buy the AI Ultrasound Solution market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospital, Clinic and Other, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the AI Ultrasound Solution market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.